IP Library › Granted Patent US 7,750,116
Granted Patent B1
US 7,750,116 · App. 11/677,029 · Granted Jul 6, 2010

Antibody drug conjugate metabolites

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,750,116
App. No.
11/677,029
Granted
Jul 6, 2010
Kind
B1
Abstract

Methods of treating a refractory or drug resistant cancer, cell proliferative disorder and tumor cells are provided. Also provided are antibody drug conjugate metabolites.

Claims (1)

1. A purified compound having the formula:

Assignments (4)
CHANGE OF NAME Recorded Feb 18, 2021
From: SEATTLE GENETICS, INC.
To: SEAGEN INC.
Reel/Frame 055334/0754 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2010
From: ALLEY, STEPHEN C.
To: SEATTLE GENETICS, INC.
Reel/Frame 024379/0045 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2007
From: DORONINA, SVETLANA O.; CERVENY, CHARLES G.; WAHL, ALAN F.
To: SEATTLE GENETICS, INC.
Reel/Frame 019537/0322 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2007
From: DORONINA, SVETLANA O.; CERVENY, CHARLES G.; WAHL, ALAN F.
To: SEATTLE GENETICS
Reel/Frame 019334/0936 →